Deakin University
Browse

Syngeneic-stem cell transplantation for HIV-related lymphoma

Version 2 2024-06-13, 17:15
Version 1 2022-05-19, 09:29
journal contribution
posted on 1999-06-24, 00:00 authored by P Campbell, H J Iland, J Gibson, D Joshua
The treatment of human immunodeficiency virus (HIV)-related lymphoma is beset by a number of therapeutic limitations. High-dose chemotherapy followed by peripheral blood stem cell transplantation (PBSCT) for relapsed disease is one option, but may be compromised by unacceptable treatment-related morbidity and mortality. We describe an HIV-positive male with relapsed immunoblastic non-Hodgkin's lymphoma (NHL) who successfully received salvage chemotherapy followed by a syngeneic PBSCT from his HIV negative (hepatitis C positive) brother. At 15 months post-transplant he remains in complete remission with low-level HIV viral load, an improved CD4 lymphocyte count and absent anti-hepatitis C antibodies. We believe selected patients with relapsed HIV-related NHL should be considered for high-dose therapy.

History

Journal

British Journal of Haematology

Volume

105

Issue

3

Pagination

795 - 798

ISSN

0007-1048

Usage metrics

    Research Publications

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC